Luma Group Closes Inaugural $410M Life Sciences Venture Capital Fund

New York-based investment firm, Luma Group, successfully closes its first life sciences venture capital fund, LumaBio I LP, with a total of $410 million in committed capital. The fund aims to invest early alongside exceptional entrepreneurs and groundbreaking science, with the flexibility to support its highest-conviction companies through key milestones from discovery to commercialization.